The Valley Desk

NCT00767949 · Interventional trial

Safety Study of iSONEP (Sonepcizumab/LT1009) to Treat Neovascular Age-related Macular Degeneration

Overall registry status Unknown

Phase 1

Conditions Neovascular Age Related Macular Degeneration

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov